INT64344

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.03
First Reported 1996
Last Reported 2006
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 1.63
Pain Relevance 0.06

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (F13a1) transferase activity, transferring acyl groups (F13a1) cytoplasm (F13a1)
Anatomy Link Frequency
platelets 1
F13a1 (Mus musculus)
Pain Link Frequency Relevance Heat
abdominal pain 1 60.00 Quite High
Restless leg syndrome 2 50.00 Quite Low
cva 9 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 16 97.68 Very High Very High Very High
Aneuploidy 1 93.68 High High
Glanzmann Thrombasthenia 1 92.72 High High
Coagulation Disorder 38 90.56 High High
Abdominal Pain 1 60.00 Quite High
Increased Venous Pressure Under Development 2 59.68 Quite High
Hemorrhage 41 59.36 Quite High
Malignant Neoplastic Disease 2 37.00 Quite Low
Cv General 3 Under Development 8 5.00 Very Low Very Low Very Low
Emergencies 5 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
On immunohistochemistry, the tumor cells were strongly positive for vimentin, moderately positive for actin along the periphery of the cytoplasm, and negative for cytokeratin, EMA, myoglobin, S-100, CEA, Factor XIIIa, HMB-45, and HAM56 and KP-1.
Positive_regulation (negative) of Factor XIIIa associated with cancer
1) Confidence 0.03 Published 1996 Journal Ultrastruct Pathol Section Abstract Doc Link 8789215 Disease Relevance 1.04 Pain Relevance 0.06
CONCLUSIONS: The healthy male relatives of men with PAD have elevated levels of fibrinogen, factor VII, and factor XIII.
Positive_regulation (elevated) of factor XIII
2) Confidence 0.02 Published 2004 Journal J. Vasc. Surg. Section Body Doc Link 15557902 Disease Relevance 0.06 Pain Relevance 0
The current understanding of its hemostatic action suggests that pharmacologic doses of rFVIIa enhance the thrombin-generating potential of activated platelets and facilitate full activation of thrombin-activatable fibrinolytic inhibitor (TAFI) and factor XIII.
Positive_regulation (activation) of factor XIII in platelets
3) Confidence 0.01 Published 2006 Journal Vascular Health and Risk Management Section Body Doc Link PMC1994012 Disease Relevance 0.53 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox